ID

15410

Description

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02396043

Link

https://clinicaltrials.gov/show/NCT02396043

Keywords

Versions (1)
  1. 5/30/16 5/30/16 -
Uploaded on

May 30, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma, Lymphoblastic NCT02396043

English

Eligibility Lymphoma, Lymphoblastic NCT02396043

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosedt-lbl
Description

Lymphoblastic T-cell lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C2853920
age:18-65years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
ann arbor stage ieto stage ive
Description

Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1]
C0432516
at lease one measurable lesion
Description

Measurable lesion

Data type

boolean

Alias
UMLS CUI [1]
C1513041
receive no chemotherapy or radiotherapy before
Description

Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1279901
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C1279901
adequate renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
Description

Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0373595
UMLS CUI [4]
C0232741
UMLS CUI [5]
C0201913
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
mismatch the inclusion criteria
Description

Mismatch Inclusion criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C1881865
UMLS CUI [1,2]
C1512693
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
Description

Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C3714787
UMLS CUI [1,2]
C1314939
UMLS CUI [1,3]
C0220922
UMLS CUI [2]
C0006826
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C1321605
UMLS CUI [3,3]
C0439801
Back to the top of the page

Similar models

Eligibility Lymphoma, Lymphoblastic NCT02396043

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoblastic T-cell lymphoma
Item
newly diagnosedt-lbl
boolean
C2853920 (UMLS CUI [1])
Age
Item
age:18-65years
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage ieto stage ive
boolean
C0432516 (UMLS CUI [1])
Measurable lesion
Item
at lease one measurable lesion
boolean
C1513041 (UMLS CUI [1])
Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly
Item
receive no chemotherapy or radiotherapy before
boolean
C0392920 (UMLS CUI [1,1])
C1279901 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1279901 (UMLS CUI [2,2])
Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
adequate renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C0201913 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Mismatch Inclusion criteria
Item
mismatch the inclusion criteria
boolean
C1881865 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited
Item
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
boolean
C3714787 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0220922 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C1321605 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial